Division of Endocrinology, Diabetes, and Nutrition

Research Activities

Genetics of osteoporosis and osteogenesis imperfecta
New understandings for the genetic basis of Type 2 diabetes and obesity, and the development of new therapeutic and prevention strategies
Characterization of growth factors for pancreatic beta cells and their potential clinical use for treatment of Type 1 diabetes
Investigation of the long-term effects of blood glucose control on prevention and delay of diabetic complications
Optimization of preoperative and postoperative care for patients undergoing pancreas transplantation
Optimization of diagnosis and treatment of cardiovascular disease in patients with diabetes
Preclinical gene therapy approaches for diabetes
Studies to determine why some people respond to certain diabetes drugs while others do not (pharmacogenomics)
Clinical trials of new therapeutic agents for the treatment of diabetes and obesity
Genetics of hypertension
Diagnosis and treatment of osteoporosis associated with kidney failure and transplantation
Studies of growth hormone replacement in adults
Genetics of longevity
Molecular studies of fat cells and how insulin works

For more information, call the University Physicians Consultation and Referral Service at 1-800-492-5538 (patients) or 1-800-373-4111 (physicians).
For diabetes referrals please call the University of Maryland Center for Diabetes and Endocrinology at 1-888-567-5468.

This page was last updated on: January 26, 2011.